Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
Status:
Withdrawn
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to assess the safety and efficacy of Acthar® Gel in
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) patients.